The role of the EP receptors for prostaglandin E 2 in skin and skin cancer

Cancer and Metastasis Reviews

Volumn 30, Issue 3-4, 2011, Pages 465-480

  Rundhaug, J E ^a   Simper, M S ^a   Surh, I ^a   Fischer, S M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

EP receptors; Epithelial; Keratinocytes; Non melanoma skin cancer; Prostaglandins

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ICOSANOID; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ARACHIDONIC ACID METABOLISM; DNA DAMAGE; DOWN REGULATION; GENE DELETION; GENOME; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION; WILD TYPE;

ANIMALS; DINOPROSTONE; HUMANS; INFLAMMATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, PROSTAGLANDIN E; SKIN; SKIN NEOPLASMS;

EID: 83855162802     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9317-9     Document Type: Review

References (93)

1. JE Rundhaug SM Fischer 2010 Molecular mechanisms of mouse skin tumor promotion Cancers (Basel) 2 2 436 482 1:CAS:528:DC%2BC3cXnslGisrY%3D
2. SM Fischer HH Lo GB Gordon K Seibert G Kelloff RA Lubet, et al. 1999 Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis Molecular Carcinogenesis 25 4 231 240 10449029 10.1002/(SICI)1098-2744(199908)25: 4<231::AID-MC1>3.0.CO;2-F 1:CAS:528:DyaK1MXltVCitrc%3D
3. K Muller-Decker G Furstenberger 2007 The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis Molecular Carcinogenesis 46 8 705 710 17546626 10.1002/mc.20326
4. KL Tober TA Wilgus DF Kusewitt JM Thomas-Ahner T Maruyama TM Oberyszyn 2006 Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development The Journal of Investigative Dermatology 126 1 205 211 16417238 10.1038/sj.jid.5700014 1:CAS:528:DC%2BD28Xlt1Wisr0%3D
5. JE Rundhaug A Pavone E Kim SM Fischer 2007 The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent Molecular Carcinogenesis 46 12 981 992 17583568 10.1002/mc.20340 1:CAS:528: DC%2BD2sXhsVOrsb7M
6. HF Tiano CD Loftin J Akunda CA Lee J Spalding A Sessoms, et al. 2002 Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis Cancer Research 62 12 3395 3401 12067981 1:CAS:528:DC%2BD38XkslWqsb4%3D
7. K Muller-Decker G Neufang I Berger M Neumann F Marks G Furstenberger 2002 Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis Proc Natl Acad Sci USA 99 19 12483 12488 12221288 10.1073/pnas.192323799 1:CAS:528:DC%2BD38XntlCkt7o%3D
8. SM Fischer A Pavone C Mikulec R Langenbach JE Rundhaug 2007 Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis Molecular Carcinogenesis 46 5 363 371 17219415 10.1002/mc.20284 1:CAS:528:DC%2BD2sXlsVWnsrg%3D
9. KM Ansari JE Rundhaug SM Fischer 2008 Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation Molecular Cancer Research 6 6 1003 1016 18567804 10.1158/1541-7786.MCR-07-2144 1:CAS:528:DC%2BD1cXnsVKhtb8%3D
10. J DiGiovanni 1992 Multistage carcinogenesis in mouse skin Pharmacology and Therapeutics 54 1 63 128 1528955 10.1016/0163-7258(92)90051-Z 1:CAS:528:DyaK38XlvVKjuro%3D
11. RL Jones MA Giembycz DF Woodward 2009 Prostanoid receptor antagonists: development strategies and therapeutic applications British Journal of Pharmacology 158 1 104 145 19624532 10.1111/j.1476-5381.2009.00317.x 1:CAS:528:DC%2BD1MXhsVKmu7bJ
12. Y Sugimoto S Narumiya 2007 Prostaglandin E receptors Journal of Biological Chemistry 282 16 11613 11617 17329241 10.1074/jbc.R600038200 1:CAS:528:DC%2BD2sXktFemtbs%3D
13. S Narumiya 2009 Prostanoids and inflammation: a new concept arising from receptor knockout mice Journal of Molecular Medicine 87 10 1015 1022 19609495 10.1007/s00109-009-0500-1 1:CAS:528:DC%2BD1MXhsVehsrjM
14. CH Tang RS Yang WM Fu 2005 Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts Journal of Biological Chemistry 280 24 22907 22916 15833739 10.1074/jbc.M500130200 1:CAS:528:DC%2BD2MXltVyht7c%3D
15. M Negishi Y Sugimoto A Ichikawa 1993 Prostanoid receptors and their biological actions Progress in Lipid Research 32 4 417 434 8309950 10.1016/0163-7827(93)90017-Q 1:CAS:528:DyaK2cXhsFersLo%3D
16. WK Wu JJ Sung CW Lee J Yu CH Cho 2010 Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms Cancer Letters 295 1 7 16 20381235 10.1016/j.canlet.2010.03.015 1:CAS:528: DC%2BC3cXntVSmsbs%3D
17. K Kiguchi T Kitamura T Moore M Rumi HC Chang D Treece, et al. 2010 Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis Cancer Prevention Research (Philadelphia, Pa.) 3 8 940 952 10.1158/1940-6207.CAPR-10- 0010 1:CAS:528:DC%2BC3cXht1GrtLzP
18. S Desai B Ashby 2001 Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor FEBS Letters 501 2-3 156 160 11470276 10.1016/S0014-5793(01)02640-0 1:CAS:528:DC%2BD3MXltlKqtbg%3D
19. Y Sugimoto M Negishi Y Hayashi T Namba A Honda A Watabe, et al. 1993 Two isoforms of the EP3 receptor with different carboxyl-terminal domains. Identical ligand binding properties and different coupling properties with Gi proteins Journal of Biological Chemistry 268 4 2712 2718 8381413 1:CAS:528: DyaK3sXkt1Slt70%3D
20. T Arakawa O Laneuville CA Miller KM Lakkides BA Wingerd DL DeWitt, et al. 1996 Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells. Structure and expression of the murine prostaglandin EP4 receptor gene Journal of Biological Chemistry 271 47 29569 29575 8939885 10.1074/jbc.271.47.29569 1:CAS:528:DyaK28XntFKmtL8%3D
21. S Tsuchiya S Tanaka Y Sugimoto M Katsuyama R Ikegami A Ichikawa 2003 Identification and characterization of a novel progesterone receptor-binding element in the mouse prostaglandin E receptor subtype EP2 gene Genes to Cells 8 9 747 758 12940822 10.1046/j.1365-2443.2003.00672.x 1:CAS:528: DC%2BD3sXnsV2nu74%3D
22. JW Regan 2003 EP2 and EP4 prostanoid receptor signaling Life Sciences 74 2-3 143 153 14607241 10.1016/j.lfs.2003.09.031 1:CAS:528:DC%2BD3sXos12qtro%3D
23. M Neumann E Dulsner G Furstenberger K Muller-Decker 2007 The expression pattern of prostaglandin E synthase and EP receptor isoforms in normal mouse skin and preinvasive skin neoplasms Experimental Dermatology 16 5 445 453 17437488 10.1111/j.1600-0625.2007.00549.x 1:CAS:528:DC%2BD2sXmtl2hsrs%3D
24. YM Sung G He SM Fischer 2005 Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development Cancer Research 65 20 9304 9311 16230392 10.1158/0008-5472.CAN-05-1015 1:CAS:528:DC%2BD2MXhtFWmu7zN
25. RL Konger SD Billings AB Thompson A Morimiya JH Ladenson Y Landt, et al. 2005 Immunolocalization of low-affinity prostaglandin E receptors, EP1 and EP2, in adult human epidermis The Journal of Investigative Dermatology 124 5 965 970 15854037 10.1111/j.0022-202X.2005.23658.x 1:CAS:528:DC%2BD2MXktFKnt7g%3D
26. JL Lee A Kim L Kopelovich DR Bickers M Athar 2005 Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer The Journal of Investigative Dermatology 125 4 818 825 16185283 10.1111/j.0022-202X. 2005.23829.x 1:CAS:528:DC%2BD2MXhtFChu73N
27. KL Tober JM Thomas-Ahner DF Kusewitt TM Oberyszyn 2007 Effects of UVB on E prostanoid receptor expression in murine skin The Journal of Investigative Dermatology 127 1 214 221 16917495 10.1038/sj.jid.5700502 1:CAS:528: DC%2BD28XhtlSqurbJ
28. KL Tober JM Thomas-Ahner T Maruyama TM Oberyszyn 2007 Possible cross-regulation of the E prostanoid receptors Molecular Carcinogenesis 46 8 711 715 17538953 10.1002/mc.20347 1:CAS:528:DC%2BD2sXpvFyksL4%3D
29. AT Black JP Gray MP Shakarjian V Mishin DL Laskin DE Heck, et al. 2008 UVB light upregulates prostaglandin synthases and prostaglandin receptors in mouse keratinocytes Toxicology and Applied Pharmacology 232 1 14 24 18597804 10.1016/j.taap.2008.05.017 1:CAS:528:DC%2BD1cXhtFCktLrP
30. I Surh J Rundhaug A Pavone C Mikulec E Abel SM Fischer 2011 Upregulation of the EP1 receptor for prostaglandin E(2) promotes skin tumor progression Molecular Carcinogenesis 50 458 468 21268127 10.1002/mc.20730 1:CAS:528:DC%2BC3MXlslCnu7s%3D
31. RL Konger SD Billings NC Prall TM Katona SC Dasilva CR Kennedy, et al. 2009 The EP1 subtype of prostaglandin E2 receptor: role in keratinocyte differentiation and expression in non-melanoma skin cancer Prostaglandins, Leukotrienes, and Essential Fatty Acids 81 4 279 290 19625175 10.1016/j.plefa.2009.05.025 1:CAS:528:DC%2BD1MXht1ais7fP
32. T Kawamori T Kitamura K Watanabe N Uchiya T Maruyama S Narumiya, et al. 2005 Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development Carcinogenesis 26 2 353 357 15564292 10.1093/carcin/bgh322 1:CAS:528:DC%2BD2MXmsVykuw%3D%3D
33. T Kawamori N Uchiya S Nakatsugi K Watanabe S Ohuchida H Yamamoto, et al. 2001 Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development Carcinogenesis 22 12 2001 2004 11751431 10.1093/carcin/22.12.2001 1:CAS:528:DC%2BD38Xos1Sntg%3D%3D
34. K Watanabe T Kawamori S Nakatsugi T Ohta S Ohuchida H Yamamoto, et al. 1999 Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis Cancer Research 59 20 5093 5096 10537280 1:CAS:528:DyaK1MXmvFelsrs%3D
35. T Ide K Egan LC Bell-Parikh GA FitzGerald 2003 Activation of nuclear receptors by prostaglandins Thrombosis Research 110 5-6 311 315 14592554 10.1016/S0049-3848(03)00418-3 1:CAS:528:DC%2BD3sXosVyhs7k%3D
36. D Breitkreutz L Braiman-Wiksman N Daum MF Denning T Tennenbaum 2007 Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium Journal of Cancer Research and Clinical Oncology 133 11 793 808 17661083 10.1007/s00432-007-0280-3 1:STN:280:DC%2BD2sris1Okug%3D%3D
37. Surh, I., Rundhaug, J. E., Pavone, A., Mikulec, C., Abel, E., Simper, M., et al. (2011b). The EP2 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors. Molecular Carcinogenesis
38. MS Battalora DA Johnston J DiGiovanni 1995 The effects of calcium antagonists on anthrone skin tumor promotion and promoter-related effects in SENCAR mice Cancer Letters 98 1 19 25 8529201 1:CAS:528:DyaK2MXpsV2nuro%3D
39. CS Trempus RJ Morris M Ehinger A Elmore CD Bortner M Ito, et al. 2007 CD34 expression by hair follicle stem cells is required for skin tumor development in mice Cancer Research 67 9 4173 4181 17483328 10.1158/0008-5472. CAN-06-3128 1:CAS:528:DC%2BD2sXltVyrsrc%3D
40. RL Konger S Brouxhon S Partillo J VanBuskirk AP Pentland 2005 The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes Experimental Dermatology 14 12 914 922 16274459 10.1111/j.1600-0625.2005.00381.x 1:CAS:528:DC%2BD2MXhtlWgsr%2FP
41. K Fukami S Inanobe K Kanemaru Y Nakamura 2010 Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance Progress in Lipid Research 49 4 429 437 20553968 10.1016/j.plipres.2010. 06.001 1:CAS:528:DC%2BC3cXhtFWqsLjK
42. EJ Thompson A Gupta GA Vielhauer JW Regan GT Bowden 2001 The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1 Neoplasia 3 5 402 410 11687951 10.1038/sj.neo.7900182 1:CAS:528: DC%2BD3MXot1Slur8%3D
43. X Ma N Kundu OB Ioffe O Goloubeva R Konger C Baquet, et al. 2010 Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities Molecular Cancer Research 8 10 1310 1318 20858737 10.1158/1541-7786.MCR-10-0003 1:CAS:528:DC%2BC3cXht12ksLnN
44. YM Sung G He DH Hwang SM Fischer 2006 Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development Oncogene 25 40 5507 5516 16607275 10.1038/sj.onc.1209538 1:CAS:528:DC%2BD28XptFCmurs%3D
45. RL Konger R Malaviya AP Pentland 1998 Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes Biochimica et Biophysica Acta 1401 2 221 234 9531979 10.1016/S0167-4889(97)00114-6 1:CAS:528:DyaK1cXhtlOjurg%3D
46. S Brouxhon RL Konger J VanBuskirk TJ Sheu J Ryan B Erdle, et al. 2007 Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness The Journal of Investigative Dermatology 127 2 439 446 16977324 10.1038/sj.jid.5700547 1:CAS:528: DC%2BD2sXlt12jug%3D%3D
47. CL Benjamin VO Melnikova HN Ananthaswamy 2008 P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer Advances in Experimental Medicine and Biology 624 265 282 18348463 10.1007/978-0-387-77574-6-21 1:CAS:528:DC%2BC3cXhtlKisbvM
48. Kim, H., Bachelor, M. A., Englehard, A., Owens, D. M., & Christiano, A. M. (2009) Hairless is respressed by tumor necrosis factor-alpha via activation of NFkB. In Annual Society for Investigative Dermatology Conference, Montreal, Canada (pp. 179).
49. KM Ansari YM Sung G He SM Fischer 2007 Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin Carcinogenesis 28 10 2063 2068 17277233 10.1093/carcin/bgm011 1:CAS:528:DC%2BD2sXhtFeqsL%2FJ
50. RL Konger GA Scott Y Landt JH Ladenson AP Pentland 2002 Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression American Journal of Pathology 161 6 2065 2078 12466123 10.1016/S0002-9440(10)64485-9 1:CAS:528:DC%2BD38Xpslemuro%3D
51. H Fujino KA West JW Regan 2002 Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2 Journal of Biological Chemistry 277 4 2614 2619 11706038 10.1074/jbc.M109440200 1:CAS:528:DC%2BD38XhtVSgsL8%3D
52. H Fujino S Salvi JW Regan 2005 Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2 Molecular Pharmacology 68 1 251 259 15855407 1:CAS:528:DC%2BD2MXlvVSqu7s%3D
53. MD Castellone H Teramoto BO Williams KM Druey JS Gutkind 2005 Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis Science 310 5753 1504 1510 16293724 10.1126/science.1116221 1:CAS:528:DC%2BD2MXht1GqsrvF
54. JK Akunda KS Chun AR Sessoms HC Lao SM Fischer R Langenbach 2007 Cyclooxygenase-2 deficiency increases epidermal apoptosis and impairs recovery following acute UVB exposure Molecular Carcinogenesis 46 5 354 362 17238138 10.1002/mc.20290 1:CAS:528:DC%2BD2sXlsVWnsrs%3D
55. KS Chun JK Akunda R Langenbach 2007 Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4 Cancer Research 67 5 2015 2021 17332329 10.1158/0008-5472.CAN-06-3617 1:CAS:528:DC%2BD2sXit12qu7w%3D
56. KS Chun R Langenbach 2007 A proposed COX-2 and PGE(2) receptor interaction in UV-exposed mouse skin Molecular Carcinogenesis 46 8 699 704 17570497 10.1002/mc.20354 1:CAS:528:DC%2BD2sXpvFylur4%3D
57. RE Maldve SM Fischer 1996 Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes Molecular Carcinogenesis 17 4 207 216 8989914 10.1002/(SICI)1098-2744(199612)17:4<207::AID-MC4>3.0.CO;2-A 1:CAS:528:DyaK2sXitFyjsQ%3D%3D
58. KS Chun HC Lao CS Trempus M Okada R Langenbach 2009 The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development Carcinogenesis 30 9 1620 1627 19587094 10.1093/carcin/bgp168 1:CAS:528:DC%2BD1MXhtFSntrfF
59. S Donnini F Finetti R Solito E Terzuoli A Sacchetti L Morbidelli, et al. 2007 EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways The FASEB Journal 21 10 2418 2430 17384145 10.1096/fj.06-7581com 1:CAS:528:DC%2BD2sXptFKhur8%3D
60. Chun, K. S., & Langenbach, R. (2011). The prostaglandin E(2) receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Mol Carcinog.
61. S Brouxhon S Kyrkanides MK O'Banion R Johnson DA Pearce GM Centola, et al. 2007 Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism Cancer Research 67 16 7654 7664 17699770 10.1158/0008-5472.CAN-06-4415 1:CAS:528:DC%2BD2sXptVGlsLk%3D
62. H Seno M Oshima TO Ishikawa H Oshima K Takaku T Chiba, et al. 2002 Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps Cancer Research 62 2 506 511 11809702 1:CAS:528:DC%2BD38XhtVyht7k%3D
63. SH Chang Y Ai RM Breyer TF Lane T Hla 2005 The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia Cancer Research 65 11 4496 4499 15930264 10.1158/0008-5472.CAN-05-0129 1:CAS:528:DC%2BD2MXks1Oht74%3D
64. T Namba Y Sugimoto M Negishi A Irie F Ushikubi A Kakizuka, et al. 1993 Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity Nature 365 6442 166 170 8396726 10.1038/365166a0 1:CAS:528:DyaK2cXitVyksLk%3D
65. N Hatae Y Sugimoto A Ichikawa 2002 Prostaglandin receptors: advances in the study of EP3 receptor signaling Journal of Biochemistry 131 6 781 784 12038972 1:CAS:528:DC%2BD38XlslKktL0%3D
66. N Kanda H Mitsui S Watanabe 2004 Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes The Journal of Allergy and Clinical Immunology 114 6 1403 1409 15577845 10.1016/j.jaci.2004.08. 041 1:CAS:528:DC%2BD2cXhtVCnsr%2FL
67. T Honda T Matsuoka M Ueta K Kabashima Y Miyachi S Narumiya 2009 Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity The Journal of Allergy and Clinical Immunology 124 4 809 818 19541354 10.1016/j.jaci.2009.04.029 1:CAS:528:DC%2BD1MXht1CqsLnI e802
68. M Bhattacharya K Peri A Ribeiro-da-Silva G Almazan H Shichi X Hou, et al. 1999 Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope Journal of Biological Chemistry 274 22 15719 15724 10336471 10.1074/jbc.274.22.15719 1:CAS:528:DyaK1MXjsV2gt70%3D
69. Y Shoji M Takahashi T Kitamura K Watanabe T Kawamori T Maruyama, et al. 2004 Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development Gut 53 8 1151 1158 15247185 10.1136/gut.2003.028787 1:CAS:528:DC%2BD2cXmvVehtb8%3D
70. Y Shoji M Takahashi N Takasuka N Niho T Kitamura H Sato, et al. 2005 Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis Carcinogenesis 26 12 2116 2122 16051640 10.1093/carcin/bgi193 1:CAS:528:DC%2BD2MXht1entL%2FO
71. SH Chang CH Liu R Conway DK Han K Nithipatikom OC Trifan, et al. 2004 Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression Proc Natl Acad Sci USA 101 2 591 596 14688410 10.1073/pnas.2535911100 1:CAS:528:DC%2BD2cXmsFGmsw%3D%3D
72. M Sonoshita K Takaku N Sasaki Y Sugimoto F Ushikubi S Narumiya, et al. 2001 Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice Nature Medicine 7 9 1048 1051 11533709 10.1038/nm0901-1048 1:CAS:528:DC%2BD3MXmvFOls7Y%3D
73. JL Goulet AJ Pace ML Key RS Byrum M Nguyen SL Tilley, et al. 2004 E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation Journal of Immunology 173 2 1321 1326 1:CAS:528:DC%2BD2cXlsVGitbY%3D
74. LP Audoly SL Tilley J Goulet M Key M Nguyen JL Stock, et al. 1999 Identification of specific EP receptors responsible for the hemodynamic effects of PGE2 American Journal of Physiology 277 3 Pt 2 H924 H930 10484412 1:CAS:528:DyaK1MXmt1Gjtrs%3D
75. RL Jones RA Armstrong H Wise 1997 Prostaglandin receptors involved in inflammatory events Advances in Experimental Medicine and Biology 400A 241 245 9547564 10.1007/978-1-4615-5325-0-35 1:CAS:528:DyaK1cXjs12is7k%3D
76. N Kanda S Koike S Watanabe 2005 Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytes Journal of Pharmacology and Experimental Therapeutics 315 2 796 804 16081678 10.1124/jpet.105.091645 1:CAS:528:DC%2BD2MXhtFyhtr%2FE
77. A Ahluwalia M Perretti 1994 Anti-inflammatory effect of prostanoids in mouse and rat skin: evidence for a role of EP3-receptors Journal of Pharmacology and Experimental Therapeutics 268 3 1526 1531 8138964 1:CAS:528: DyaK2cXitlKqsbs%3D
78. SM Foord B Marks M Stolz E Bufflier NJ Fraser MG Lee 1996 The structure of the prostaglandin EP4 receptor gene and related pseudogenes Genomics 35 1 182 188 8661119 10.1006/geno.1996.0337 1:CAS:528:DyaK28Xkt12qtrc%3D
79. Simper, M. S., Bowen, R. A., Surh, I., & Fischer, S. M (2010) Overexpression of prostaglandin E2 EP4 receptor enhances mouse skin tumorigenesis. In Annual Meeting of the American Association for Cancer Research, Washington, DC (pp. 2462)
80. Simper, M. S., Bowen, R. A., Surh, I., & Fischer, S. M. (2011) The tumor promoting activity of the prostaglandin E2 EP4 receptor in mouse skin. In Annual Meeting of the American Association for Cancer Research (pp. 912)
81. L Aoudjit A Potapov T Takano 2006 Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor American Journal of Physiology. Renal Physiology 290 6 F1534 F1542 16396944 10.1152/ajprenal.00267. 2005 1:CAS:528:DC%2BD28XlvVertrY%3D
82. M Mutoh K Watanabe T Kitamura Y Shoji M Takahashi T Kawamori, et al. 2002 Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis Cancer Research 62 1 28 32 11782353 1:CAS:528:DC%2BD38XntlyqtA%3D%3D
83. X Ma N Kundu S Rifat T Walser AM Fulton 2006 Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis Cancer Research 66 6 2923 2927 16540639 10.1158/0008-5472.CAN-05-4348 1:CAS:528:DC%2BD28XitlersL4%3D
84. K Kabashima M Nagamachi T Honda C Nishigori Y Miyachi Y Tokura, et al. 2007 Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors Laboratory Investigation 87 1 49 55 17075575 10.1038/labinvest.3700491 1:CAS:528:DC%2BD28XhtlaktrjJ
85. M Minami K Shimizu Y Okamoto E Folco ML Ilasaca MW Feinberg, et al. 2008 Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation Journal of Biological Chemistry 283 15 9692 9703 18270204 10.1074/jbc.M709663200 1:CAS:528:DC%2BD1cXkt1aksLk%3D
86. K Soontrapa T Honda D Sakata C Yao T Hirata S Hori, et al. 2011 Prostaglandin E2-prostoglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression Proceedings of the National Academy of Sciences of the United States of America 108 16 6668 6673 21460251 10.1073/pnas.1018625108 1:CAS:528:DC%2BC3MXlt1Khtbg%3D
87. K Subbaramaiah C Hudis SH Chang T Hla AJ Dannenberg 2008 EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange Journal of Biological Chemistry 283 6 3433 3444 18083712 10.1074/jbc.M705409200 1:CAS:528:DC%2BD1cXhtlyis7k%3D
88. H Fujino W Xu JW Regan 2003 Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases Journal of Biological Chemistry 278 14 12151 12156 12566441 10.1074/jbc.M212665200 1:CAS:528:DC%2BD3sXisVOnsbw%3D
89. H Fujino JW Regan 2006 EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein Molecular Pharmacology 69 1 5 10 16204467 1:CAS:528:DC%2BD28XktlWhtg%3D%3D
90. A Kambe G Iguchi Y Moon H Kamitani T Watanabe TE Eling 2008 Regulation of EP4 expression via the Sp-1 transcription factor: inhibition of expression by anti-cancer agents Biochimica et Biophysica Acta 1783 6 1211 1219 18346464 10.1016/j.bbamcr.2008.01.032 1:CAS:528:DC%2BD1cXmtVahtL8%3D
91. T Singh M Vaid N Katiyar S Sharma SK Katiyar 2011 Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E and prostaglandin E receptors Carcinogenesis 32 1 86 92 20974686 10.1093/carcin/bgq215 1:CAS:528: DC%2BC3MXjs1Gmtr0%3D
92. O Rho DJ Kim K Kiguchi J Digiovanni 2011 Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis Molecular Carcinogenesis 50 4 264 279 20648549 10.1002/mc.20665 1:CAS:528:DC%2BC3MXktFKit7k%3D
93. GT Bowden 2004 Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling Nature Reviews. Cancer 4 1 23 35 14681688 10.1038/nrc1253 1:CAS:528:DC%2BD3sXpvVGnu70%3D